Health & Climate Pulse

The Trump administration seeks to loosen the Common Rule by redefining undue influence, aiming to slash administrative burdens on investigators and...

• Pivotal milestone: First patient dosed in CLINCH-3 targets 3L+ CLDN18.2+ gastric/GEJ adenocarcinoma, supported by BTD and Phase I/II data.
• Disease...

The BMJ reports US officials used a flawed data-mining algorithm for mRNA vaccine safety that set Pfizer and Moderna as mutual baselines, masking...

• 87% of 111 PFAS-containing human medicines already have non-PFAS alternatives available.
• Fluorine is added mainly for stability and formulation,...

• Biomarker success, outcome failure: Pelacarsen lowered Lp(a) via antisense targeting but the Phase III Lp(a)HORIZON trial missed its primary...

Governments worldwide spent billions stockpiling Tamiflu after Roche hid trial data, yet a 2026 randomized trial found it raised mortality in...

Drugmakers are laying groundwork for commercial pharmaceutical research and manufacturing in low Earth orbit, with hopes to begin clinical trials in 2028.

Acumen Pharmaceuticals' transcript highlights plans to use proximal amyloid and tau while incorporating downstream biomarkers, and questions whether...

The EU Global Health Resilience Initiative centers on a high-level UNGA81 side event to present priorities and advance coordinated action with...

• Measurable targets: Average daytime light above 1,000 lux linked to 16% lower dementia risk; over 1.4 hours above 3,000 lux or 0.7 hours above 5,000...

U.S. patients access breakthrough cures three years earlier than other high-income countries and gain availability of 88% of new medicines.

Immunity and wellness products face a nationwide recall due to the risk of 'significant medical events' or death.

• 5% mean weight loss at 60 mg after 12 weeks with no plateau observed, statistically significant across doses
• Favorable GI profile versus oral...

The Gates Foundation is investing $1B over two years in AI tools for health workers in the poorest countries, aiming to reverse slowing progress on...

Headlines flag next-day risks from daily sleep prescriptions, yet the article supplies zero safety data and instead promotes B-vitamin formulas plus circadian lifestyle tips.

Lonza broke ground on a commercial spray-drying facility in Bend, Ore., set to create over 80 jobs and finish in 2029.

Samsung Biologics secured a...

Experts at an FDA meeting called for clear regulatory infrastructure before psychedelic therapies reach wider use.

• Provider training: Sessions...

McKesson raised FY2027 EPS guidance to $44.20-$45.00 after its Oncology and Multispecialty segment posted 33% top-line and 41% operating profit...

The 1976 discovery of IL-2 by Robert C. Gallo enabled scientists to grow and maintain human T cells in long-term culture for the first time.

• This...

Lack of federal guidance on pharmaceutical tariff exemptions just two weeks before the Sept. 29 deadline is frightening investors and forcing biotech...